Keyphrases
1,8-cineole
7%
Abbreviated Profile of Hearing Aid Benefit
10%
Active Middle Ear Implant
12%
Advanced Squamous Cell Carcinoma
9%
Bispecific Antibody
8%
Brachytherapy
6%
Cancer Patients
9%
Carcinoma
7%
Carcinoma Cell Lines
8%
Chronic Rhinosinusitis
19%
Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
23%
Cisplatin
11%
Clinical Trials
8%
Epithelial Cell Adhesion Molecule (EpCAM)
7%
German Society
7%
Germany
11%
Head-and-neck
64%
Head-and-neck Cancer
100%
Head-and-neck Region
8%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
87%
Hearing Aid Fitting
7%
Hearing Aids
11%
Hearing Impairment
16%
Immune Response
6%
Locally Advanced
9%
Mepolizumab
7%
Metastasis
7%
Myeloid Dendritic Cells
7%
Nasal Polyps
16%
Natural Killer Cells
9%
Neck Surgery
8%
Overall Survival
11%
Paclitaxel
9%
Plasmacytoid Dendritic Cells
10%
Programmed Death-ligand 1 (PD-L1)
6%
Radiochemotherapy
8%
Radiotherapy
12%
Salivary Gland
7%
Squamous Carcinoma Cells
10%
Squamous Cell Cancer
17%
Squamous Cell Carcinoma of Head
33%
Stem Cells
10%
T Cells
6%
Toll-like
12%
Treatment Options
7%
Tumor
39%
Tumor Cells
24%
Tumor Stage
6%
Upper Airway Stimulation
8%
Vibrant Soundbridge
9%
Medicine and Dentistry
Adverse Event
5%
Atresia
8%
Biological Marker
8%
Botulinum Toxin
5%
Brachytherapy
8%
Cancer
7%
Cancer Cell
11%
Cancer Therapy
5%
Chemoradiotherapy
10%
Chemotherapy
5%
Chronic Rhinosinusitis
21%
Cisplatin
6%
Clinical Trial
9%
Diagnosis
11%
Disease
23%
Head and Neck Cancer
64%
Head and Neck Squamous Cell Carcinoma
37%
Head and Neck Squamous Cell Carcinoma Cell Line
5%
Head and Neck Surgery
10%
Head and Neck Tumor
6%
Hearing Impairment
8%
Immunotherapy
10%
In Vitro
7%
Infection
6%
Laryngeal Cancer
9%
Laryngectomy
6%
Larynx
7%
Malignant Neoplasm
15%
Mepolizumab
7%
Metastatic Carcinoma
9%
Middle Ear Implantation
12%
Mucosa
5%
Nasal Polyp
21%
Neck
45%
Neoplasm
60%
Otoplasty
5%
Otorhinolaryngology
8%
Overall Survival
12%
Paclitaxel
6%
Primary Tumor
5%
Quality of Life
5%
Radiation Therapy
16%
Recurrent Disease
9%
Salivary Gland
9%
Squamous Cell
11%
Squamous Cell Carcinoma
25%
Stem Cell
15%
Surgery
13%
Symptom
8%
Tumor Cell
16%
